CLINUVEL to advance novel pharmaceutical formulations in preclinical program
Executive summary first biocompatible pharmaceutical formulations progress to preclinical modelsnew sustained-release drug…
LEQEMBI (lecanemab) IV Maintenance Dosing for the Treatment of Early Alzheimers Disease Approved in China
September 28, 2025 19:30 ET | Source: Biogen Inc. TOKYO and CAMBRIDGE,…
Demand for charitable services is increasing around the world, according to new Charities Aid Foundation research
LONDON, Sept. 24, 2025 /PRNewswire/ -- Charities around the world say that…
Myriad Genetics and SOPHiA GENETICS to Develop an Innovative Companion Diagnostic Offering in Liquid Biopsy
SALT LAKE CITY and BOSTON, Sept. 23, 2025 /PRNewswire/ -- Myriad Genetics (Nasdaq: MYGN),…
Immuneering to Discuss Recently Announced Overall Survival Data from Phase 2a Clinical Trial of Atebimetinib + mGnP in First-Line Pancreatic Cancer Patients on Monday, September 29, 2025
NEW YORK, Sept. 26, 2025 (GLOBE NEWSWIRE) -- Immuneering Corporation (Nasdaq: IMRX),…
Glucose Health, Inc. Announces Officer Changes Effective September 30, 2025
September 26, 2025 16:00 ET | Source: Glucose Health BENTONVILLE, Ark., Sept.…
Fermenta Biotech Limited Certified as a Great Place to Work
Recognition by Great Place to Work® underscores Fermenta's people-first culture and strong…
Bridging Fitness and Medicine: Manipal Hospitals’ ‘Know Your Doctor’ Session for Trainers
BENGALURU, India, Sept. 24, 2025 /PRNewswire/ -- Fitness isn't just about hitting…
Oculis Publishes Notification of Transactions by Person Discharging Managerial Responsibilities
Accessibility: Skip TopNav ZUG, Switzerland, Sept. 26, 2025 (GLOBE NEWSWIRE) -- The…
Palisade Bio Announces Adjournment of Special Meeting of Stockholders Due to Lack of Quorum
Carlsbad, CA, Sept. 26, 2025 (GLOBE NEWSWIRE) -- Palisade Bio, Inc. (Nasdaq:…